Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
about
Pneumococcal conjugate vaccines for preventing otitis mediaClinical Practice Guideline: Otitis Media with Effusion (Update).Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in childrenPneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination.Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia.Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia.Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children.Korean clinical practice guidelines: otitis media in childrenNasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.The post-vaccine microevolution of invasive Streptococcus pneumoniae.Risk Factors of Early Otitis Media in the Danish National Birth Cohort.Epidemiology and risk factors for pneumonia severity and mortality in Bangladeshi children <5 years of age before 10-valent pneumococcal conjugate vaccine introduction.Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: protection at what price in the Thai context?The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia.Role of pneumococcal vaccination in prevention of pneumococcal disease among adults in SingaporeAcute respiratory infection and pneumonia in India: a systematic review of literature for advocacy and action: UNICEF-PHFI series on newborn and child health, India.Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.Acute bacterial meningitis in infants and children: epidemiology and management.A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older.Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review.Risk Factors for Outpatient Use of Antibiotics in Children with Acute Respiratory Illnesses.Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.Bacteremia in previously healthy children in emergency departments: clinical and microbiological characteristics and outcome.Decreased paediatric antibiotic consumption in France between 2000 and 2010.Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option.Estimating the distribution of morbidity and mortality of childhood diarrhea, measles, and pneumonia by wealth group in low- and middle-income countries.
P2860
Q24197520-AC456A3F-70AE-4C69-BAA0-FAF5ED69A774Q30277634-B38D66F8-B96C-4BB3-B1AA-B852E72B4175Q34516718-C74FFA79-05DD-4972-A892-186BF33A2B81Q34606511-22439C69-3774-4327-98A8-95F7A2D18966Q35134469-A284779B-1746-4080-8E3E-E9D6AFB6B842Q35425552-86B3929E-9926-4434-A8E8-C030D8D4CD16Q35915846-F5AC4783-F80A-45E5-A35A-EBA40A6FA424Q36134554-9878959F-D00C-4F72-8030-EBC2FC058A54Q36153943-191A0DBC-ABC2-4BB4-BB77-608DF2E50E67Q36192266-191ECA1E-28D6-4B7C-86FC-70CD3490ACCBQ36194002-CAD31F9E-FF47-490A-B0A1-843C2456E4BCQ36215294-FBAD417B-5DDB-4DB3-B26A-F79AB7EA3960Q36341662-5D5D97BD-90D9-4E08-A78C-A7C05DCD0595Q36713715-9A59DE52-54FF-4AE2-BC9B-EAABA141CBB4Q37068915-C27D768A-EB37-467A-9535-8C2BFDC0DA2CQ37685565-423D52F4-37AA-4955-8AC2-824C0BDBB5F9Q37863381-46CFF414-6CE1-49D0-ABB2-D1E0876AD1FAQ37908267-A7EE6AFB-48FC-45D5-86D9-F6ACFC470593Q37945754-4F5E93CA-6F95-4F5B-B15A-8FF2F427F3EFQ38220556-CB6F21D6-9109-4B2E-99E0-1BD63C39B08DQ38924170-5ED0676D-1D9F-46CC-9C08-962F5699A2B1Q38930905-0BB1E7FF-2A38-426C-B4FB-A2BCA73683F3Q39657425-D6511547-7F33-4282-ABC7-73D24883913BQ41727561-EC0570FF-E45B-4D26-B97B-F6053999E825Q47912520-E70E6EFB-3079-43F2-BAAB-8BC77892E55AQ55315176-60D2FD88-C125-4DE9-ADA1-B7E87F2B2AFAQ55518622-27846479-E244-464E-B8F7-781DFCBC3231
P2860
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
@en
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
@nl
type
label
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
@en
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
@nl
prefLabel
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
@en
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
@nl
P50
P356
P1433
P1476
Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis
@en
P2093
Aida Bianco
Paolo Marinelli
P304
P356
10.1542/PEDS.2008-3422
P407
P577
2009-06-01T00:00:00Z